retatrutide weight loss phase 2 trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a Phase 2 Trial of Retatrutide

For people who can tolerate the side effects (about 88.7% completed TRIUMPH-1), it produces remarkable results with an acceptable safety profile based on available data

Rollout of surgery has been very slow with tiny penetration in society despite decades of trying, compared with the drugs which are easy to roll out widely

About Press Copyright Contact us Creators Advertise Developers Terms Privacy Policy & Safety How YouTube works Test new features NFL Sunday Ticket 2026 Google LLC

Pettinelli P, Del Pozo T, Araya J, Rodrigo R, Araya AV, Smok G, Csendes A, Gutierrez L, Rojas J, Korn O, Maluenda F, Diaz JC, Rencoret G, Braghetto I, Castillo J, Poniachik J, Videla LA

Knight, MD, and his board-certified physician assistants use GLP-1 medications like semaglutide to promote weight loss

The disability data alone tells the story